Order Article Reprints

Manso L, Moreno F, Márquez R, Castelo B, Arcediano A, Arroyo M, Ballesteros AI, Calvo I, Echarri MJ, Enrech S, et al. Use of Bevacizumab as a First-Line Treatment for Metastatic Breast Cancer. Current Oncology. 2015; 22(2):51-60. https://doi.org/10.3747/co.22.2210

Manso, L., F. Moreno, R. Márquez, B. Castelo, A. Arcediano, M. Arroyo, A.I. Ballesteros, I. Calvo, M.J. Echarri, S. Enrech, and et al. 2015. "Use of Bevacizumab as a First-Line Treatment for Metastatic Breast Cancer" Current Oncology 22, no. 2: 51-60. https://doi.org/10.3747/co.22.2210

Manso, L., Moreno, F., Márquez, R., Castelo, B., Arcediano, A., Arroyo, M., Ballesteros, A. I., Calvo, I., Echarri, M. J., Enrech, S., Gómez, A., del Val, R. G., López–Miranda, E., Martín–Angulo, M., Martínez–Jañez, N., Olier, C., & Zamora, P. (2015). Use of Bevacizumab as a First-Line Treatment for Metastatic Breast Cancer. Current Oncology, 22(2), 51-60. https://doi.org/10.3747/co.22.2210